Epilepsy Trial, Recruiting NCT06545708 Sponsor: Hospices Civils de Lyon Condition: Epilepsy
Back to Epilepsy

Epilepsy Trial, Recruiting

NCT06545708
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • The child is between 5 and 14 years old
  • Parents or guardians do not object to the child taking part in the study
  • The child does not have a major cognitive impairment and is able to understand and follow instructions
  • The child is covered by a social security scheme (health insurance or equivalent)
  • The child is motivated and willing to take part in the study
  • The child is proficient in the French language

For children in the healthy control group:

  • The child has no history of neurological or psychiatric conditions

For children in the seizure disorder group:

  • The child has been diagnosed with a specific type of childhood epilepsy called self-limited epilepsy with centro-temporal spikes (a common and age-related form of epilepsy), diagnosed by a qualified healthcare professional
  • The child has no history of neurological or psychiatric conditions other than this specific type of epilepsy

Who may not be able to join:

  • Children who have a major cognitive impairment or are unable to understand and follow instructions
  • Children (or their parents/guardians) who do not wish to participate in the study
  • Minors who are pregnant or breastfeeding

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 21 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 04 27 85 65 78

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
13 November 2024
Est. completion
1 November 2026

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Performance obtained in melodic tasks; Performance obtained in melodic tasks; Performance obtained in rhythmic tasks; Performance obtained in rhythmic tasks

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov